Study identifier:D2287R00198
ClinicalTrials.gov identifier:NCT06422663
EudraCT identifier:N/A
CTIS identifier:N/A
A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
Moderate-to-Severe Asthma
N/A
No
-
All
500
Observational
12 Years - 130 Years
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Moderate-to-Severe Asthma enroll 500 subjects | - |